Provided by Tiger Trade Technology Pte. Ltd.

SeaStar Medical Holding Corporation

3.19
-0.1600-4.78%
Post-market: 3.190.00000.00%17:20 EDT
Volume:55.94K
Turnover:183.35K
Market Cap:14.06M
PE:-0.84
High:3.41
Open:3.39
Low:3.19
Close:3.35
52wk High:12.50
52wk Low:2.07
Shares:4.41M
Float Shares:4.27M
Volume Ratio:1.06
T/O Rate:1.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8118
EPS(LYR):-5.8608
ROE:-356.87%
ROA:-102.67%
PB:3.27
PE(LYR):-0.54

Loading ...

Company Profile

Company Name:
SeaStar Medical Holding Corporation
Exchange:
NASDAQ
Establishment Date:
2007
Employees:
18
Office Location:
3513 Brighton Boulevard,Suite 410,Denver,Colorado,United States
Zip Code:
80216
Fax:
- -
Introduction:
SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. SeaStar Medical Holding Corporation is headquartered in Denver, Colorado.

Directors

Name
Position
Eric Schlorff
Chief Executive Officer and Director
Jennifer A. Baird
Chair of the Board and Director
Bernadette N. Vincent
Director
John Neuman
Director
Kenneth Van Heel
Director

Shareholders

Name
Position
Eric Schlorff
Chief Executive Officer and Director
Michael Messinger
Chief Financial Officer
Kevin Chung
Chief Medical Officer